What an incredible TCT 2025 @crfheart ⭐️Winner of Linnemeier Award ⭐️Best Structural Case (presented by superstar Morristown IM PGY3 @ChantalAsselin) I am still overwhelmed by the amount of support and affection that I have received. To all my mentors and friends who have

Day 2 at #TCT2025 delivered in a BIG way! 💡 Breakthroughs, bold ideas, and brilliant minds came together to shape tomorrow’s heart care. 🫶 #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @MartyBLeon @Drroxmehran

This slide just can’t catch a break. Every time I try to make it concise, a new trial drops the next day. This time it’s about the timing of complete revascularization in ACS. After the trial showing noninferiority of the immediate approach (BIOVASC), the one showing superiority

TCT 2025 LATE BREAKING CLINICAL TRIALS: One LINER SUMMARY 📸 AT A GLANCE ⭐️ What a phenomenal scientific meeting! Congratulations to all the presenters & leaders for their innovation, hard work and knowledge sharing. Thank you @TCTConference @TCTMD @crfheart team for a

And now, the curves we’ve all been waiting to see — those of TAVI and surgery in PARTNER 3 at 7 years: it’s an even match across the board, I would say, although I still can’t quite understand why there are so many more surgical patients lost to follow-up. #TCT2025

SELUTION DeNovo - non inferiority for TVF at 1 yr demonstrated. Randomisation before lesion prep ➡️ 20% DES use in DEB arm ➡️ 50% non inferiority margin of overall tvf in both arms !!!!! ➡️ TVF 4.4 vs 5.3% in des and deb arms This is a landmark moment- analogous to introduction

📸 Scenes from this morning’s opening session at #TCT2025 — featuring powerful insights and inspiration from just some of the visionaries driving the future of cardiovascular care. 🫀💡✨ #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos

Register here, on site or online https://t.co/KB32UvBJPD

Great discussion on failed #TAVR management #NYV2025 @TCTMD with @TCTMD_Yael @TsuyoshiKaneko1 including redo TAVR and TAVR explant.

Transcatheter Closure of LCx to Coronary Sinus Fistula In this #JACCCR case you will find: 🧩multimodality diagnostic approach 🛠️procedural planning 🧶role & technical challenges of coils Read the case from @DL_Feldman @jcecharte @MatteoSturlaM et al. 🔗 https://t.co/SI9dSSG4XY

@crfheart #NYValves2025 Clinical & QOL Outcomes w PASCAL System in Early Experience From STS/ ACC TVT Registry @MHIF_Heart @nimeshdesai 🔹STS registry valuable for post-marketing surveillance 🔹25% not in echo analysis & 40% not in QOL analysis 🔹Did any subgroups have

@crfheart #NYValves2025 #LBCT 2-yr Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study @GilbertTangMD 🔹No device-related deaths, disabling strokes, or reinterventions 🔹Improvements in stroke volume, CO, RV

Kicking off #NYValves2025 with a full day of hands-on learning and dynamic sessions for the entire #HeartTeam! 💥 Whether you're in imaging, intervention, or heart failure care, this is your moment to advance your skills and drive meaningful change in structural heart treatment.

Day 2 at #NYValves2025 did not disappoint! 🎉Cutting-edge late-breaking science, live cases, and vibrant networking filled the halls. Swipe through these moments capturing the passion and progress driving our field forward! 🚀 #CardioX #CardioTwitter #CardioEd #CardioResearch

Part 3️⃣: @modine_thomas, Lionnel Leroux, @TernacleJ & @guilbon, Atlantic Valve Academy, complete LuX-Valve #TTVR in an 81yo male with COPD, paroxysmal AF & severe TR. After confirming seal, the valve is released. The system is de-flexed & retracted into the RA.

What a kickoff to #NYValves2025! 🚀 From cutting-edge science to hands-on sessions, today was packed with innovation, education, and amazing connections. Here’s a glimpse of the excitement from Day 1! 🔥🫀 #CardioX #CardioTwitter #CardioEd #CardioResearch @jgranadacrf

Welcome to #NYValves2025! 🎉 Drs. Juan Granada and Martin Leon kick off three powerful days of structural heart innovation, connection, and education in NYC. Let’s go! 🫀💥

It’s officially go time! 🚀 #NYValves2025 kicks off with our Opening Session — the start of 3 powerful days filled with expert insights, live education, & the future of structural heart care. 🫀💡 @jgranadacrf @MartyBLeon @PhilGenereuxMD @MayraGuerreroMD @MariellJessup @vumcvalve

#NYValves2025 is almost here! 🎉 Stay connected with real-time updates, expert takeaways, and behind-the-scenes moments from our Social Media Ambassadors. Follow along for the latest from the frontlines of innovation! https://t.co/L3L8LHQ1RS #CardioEd #CardioResearch

Late-breaking clinical trials announced for New York Valves 2025 @CRFHeart #cardiology #TAVR #mitralvalve #tricuspidvalve